216 related articles for article (PubMed ID: 14123637)
1. MAPLE SYRUP URINE DISEASE.
VOYCE MA; MONTGOMERY JN; LYNCH GA; BOWMAN JK
Br Med J; 1964 May; 1(5393):1293. PubMed ID: 14123637
[No Abstract] [Full Text] [Related]
2. [MAPLE SYRUP URINE DISEASE].
TIMMERMANS J
Maandschr Kindergeneeskd; 1963 Oct; 31():337-47. PubMed ID: 14100237
[No Abstract] [Full Text] [Related]
3. MAPLE-SYRUP-URINE DISEASE. REPORT OF A CASE, WITH A PEDIGREE.
LONSDALE D; BARBER DH
N Engl J Med; 1964 Dec; 271():1338-41. PubMed ID: 14214646
[No Abstract] [Full Text] [Related]
4. MAPLE SYRUP URINE DISEASE.
SNYDERMAN SE; HOLT LE
J Maine Med Assoc; 1964 Jan; 55():3-5. PubMed ID: 14109847
[No Abstract] [Full Text] [Related]
5. [CLINICAL, BIOCHEMICAL, AND NEUROPATHOLOGIC ASPECTS OF MAPLE SYRUP URINE DISEASE. A KETOACIDURIA OF THE OPEN CHAIN AMINOACIDS LEUCINE, ISOLEUCINE AND VALINE].
SILBERMANSCHWARTZMAN J
An Fac Med Lima; 1963 Sep; 46():339-65. PubMed ID: 14122039
[No Abstract] [Full Text] [Related]
6. MAPLE SYRUP URINE DISEASE, WITH PARTICULAR REFERENCE TO DIETOTHERAPY.
SNYDERMAN SE; NORTON PM; ROITMAN E; HOLT LE
Pediatrics; 1964 Oct; 34():454-72. PubMed ID: 14212461
[No Abstract] [Full Text] [Related]
7. Plasma amino acid analyses in two cases of maple syrup urine disease.
Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
[TBL] [Abstract][Full Text] [Related]
8. DIETARY TREATMENT OF A CHILD WITH MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA).
WESTALL RG
Arch Dis Child; 1963 Oct; 38(201):485-91. PubMed ID: 14065992
[No Abstract] [Full Text] [Related]
9. MAPLE SYRUP URINE DISEASE: A MANIFESTATION OF AN UNUSUAL METABOLIC ERROR.
DANCIS J
Clin Pediatr (Phila); 1964 Jun; 3():365-7. PubMed ID: 14154327
[No Abstract] [Full Text] [Related]
10. LATE MANIFESTING VARIANT OF BRANCHED-CHAIN KETOACIDURIA (MAPLE SYRUP URINE DISEASE).
KIIL R; ROKKONES T
Acta Paediatr (Stockh); 1964 Jul; 53():356-64. PubMed ID: 14184314
[No Abstract] [Full Text] [Related]
11. Diagnosis of maple syrup urine disease by determination of L-valine, L-isoleucine, L-leucine and L-phenylalanine in neonatal blood spots by gas chromatography-mass spectrometry.
Deng C; Deng Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):261-8. PubMed ID: 12860033
[TBL] [Abstract][Full Text] [Related]
12. Semiquantitation of leucine, isoleucine, and valine by thin-layer chromatography in management of maple-syrup urine diseases.
Allen RJ; Frey HJ; Fleming LM; Owings CL
Clin Chem; 1972 May; 18(5):413-6. PubMed ID: 5019114
[No Abstract] [Full Text] [Related]
13. THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE.
DANCIS J; HUTZLER J; LEVITZ M
Pediatrics; 1963 Aug; 32():234-8. PubMed ID: 14044451
[No Abstract] [Full Text] [Related]
14. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
Kindt E; Halvorsen S
Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
[TBL] [Abstract][Full Text] [Related]
15. [Disorders of leucine, isoleucine and valine metabolism (maple syrup urine disease)].
Vulović D; Vilhar N; Hajduković R; Marjanović B; Stojanović Lj
Srp Arh Celok Lek; 1975 May; 103(5):419-36. PubMed ID: 1188483
[No Abstract] [Full Text] [Related]
16. [Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease].
Templier I; Reymond JL; Nguyen MA; Boujet C; Lantuejoul S; Beani JC; Leccia MT
Ann Dermatol Venereol; 2006 Apr; 133(4):375-9. PubMed ID: 16733455
[TBL] [Abstract][Full Text] [Related]
17. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
Methods Mol Biol; 2022; 2546():65-81. PubMed ID: 36127579
[TBL] [Abstract][Full Text] [Related]
18. Treatment of the acute crisis in maple syrup urine disease.
Nyhan WL; Rice-Kelts M; Klein J; Barshop BA
Arch Pediatr Adolesc Med; 1998 Jun; 152(6):593-8. PubMed ID: 9641714
[TBL] [Abstract][Full Text] [Related]
19. Maple syrup urine disease; an inborn error of the metabolism of valine, leucine, and isoleucine associated with gross mental deficiency.
MACKENZIE DY; WOOLF LI
Br Med J; 1959 Jan; 1(5114):90-1. PubMed ID: 13608087
[No Abstract] [Full Text] [Related]
20. [Maple syrup urine disease. (Valine-leucine-uria)].
Platt D; Beneke G; Peiffer J; Schmidt GW
Med Welt; 1966 May; 19():1089-93. PubMed ID: 5974899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
